scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.INF.0000168749.82105.64 |
P8608 | Fatcat ID | release_vyzzwwp4qnb27pbupzfhria2sa |
P698 | PubMed publication ID | 15999007 |
P50 | author | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
Barbara J. Stoll | Q64689168 | ||
Rosemary D. Higgins | Q120839249 | ||
P2093 | author name string | Michelle Walsh | |
Ronald Goldberg | |||
Shahnaz Duara | |||
Nellie I Hansen | |||
William Oh | |||
Abbot Laptook | |||
Avroy A Fanaroff | |||
Ellen Hale | |||
P433 | issue | 7 | |
P921 | main subject | sepsis | Q183134 |
maternal health | Q6786626 | ||
Gram-negative bacteria | Q632006 | ||
birth mass | Q4128476 | ||
preterm infant | Q45051448 | ||
child health | Q57354899 | ||
P304 | page(s) | 635-639 | |
P577 | publication date | 2005-07-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. | |
P478 | volume | 24 |
Q37670523 | Age-Appropriate Functions and Dysfunctions of the Neonatal Neutrophil |
Q54458856 | Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge. |
Q40098922 | Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies |
Q35634083 | Antibiotic Resistance in Neonatal Intensive Care Unit Pathogens: Mechanisms, Clinical Impact, and Prevention Including Antibiotic Stewardship |
Q36996661 | Antibiotic Therapy for Very Low Birth Weigh Newborns in NICU. |
Q91729183 | Antibiotic regimens for neonatal sepsis - a protocol for a systematic review with meta-analysis |
Q91651189 | Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States |
Q27003877 | Antibiotic use and misuse in the neonatal intensive care unit |
Q37339114 | Antimicrobial-resistant pathogens: an emerging pediatric threat |
Q89082181 | Association between early antibiotic exposure and bronchopulmonary dysplasia or death |
Q37106133 | Attenuation of lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelial cells by hypoxia |
Q28082173 | Bacterial meningitis in infants |
Q37503327 | Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis? |
Q90000681 | Challenges in developing a consensus definition of neonatal sepsis |
Q37316463 | Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury |
Q34138000 | Choosing the right empirical antibiotics for neonates |
Q43721449 | Ciprofloxacin prevents myelination delay in neonatal rats subjected to E. coli sepsis. |
Q36089570 | Clinical Relevance of Pathogens Detected by Multiplex PCR in Blood of Very-Low-Birth Weight Infants with Suspected Sepsis - Multicentre Study of the German Neonatal Network |
Q38840297 | Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship |
Q30908704 | Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis |
Q43185848 | Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis |
Q41715773 | Comparison of changes in etiologic microorganisms causing early-onset neonatal sepsis between preterm labor and preterm premature rupture of membranes |
Q44525900 | Cord blood monocytes, neutrophils and lymphocytes from preterm and full-term neonates show multiple aberrations in signalling profiles measured using phospho-specific whole-blood flow cytometry |
Q35534348 | Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants |
Q40331820 | Diagnosis and treatment of neonatal septic shock |
Q44460722 | Diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6 and immunoglobulin M. |
Q50231917 | Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress |
Q36274174 | Diversity and composition of vaginal microbiota of pregnant women at risk for transmitting Group B Streptococcus treated with intrapartum penicillin |
Q26770010 | Early and Late Infections in Newborns: Where Do We Stand? A Review |
Q33559246 | Early and late onset sepsis in late preterm infants |
Q36443301 | Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units |
Q34838991 | Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues |
Q38046913 | Early onset sepsis in very low birth weight newborn infants |
Q30487006 | Early-life programming of later-life brain and behavior: a critical role for the immune system |
Q37544901 | Early-onset neonatal sepsis. |
Q35065880 | Effect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats |
Q39492202 | Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates |
Q46166707 | Empirical antibiotic treatment and the risk of necrotizing enterocolitis and death in very low birth weight neonates |
Q36958228 | Empirical use of antibiotic therapy in the prevention of early onset sepsis in neonates: a pilot study |
Q91937986 | Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q38704288 | Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q91468366 | Fetal inflammation is associated with persistent systemic and hippocampal inflammation and dysregulation of hippocampal glutamatergic homeostasis |
Q33378951 | Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth |
Q36616164 | Flow cytometry in the detection of neonatal sepsis |
Q36789328 | Genetic association studies in VLBW infants exemplifying susceptibility to sepsis--recent findings and implications for future research |
Q36609479 | Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis |
Q54343832 | Group B streptococcus and Escherichia coli colonization in pregnant women and neonates in Lithuania. |
Q34985330 | Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis |
Q34433080 | High DMBT1 concentrations in breast milk correlate with increased risk of infection in preterm and term neonates |
Q36452369 | How to optimize the evaluation and use of antibiotics in neonates |
Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
Q35869018 | Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis |
Q38660625 | Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. |
Q43072519 | Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis |
Q99237939 | Impaired Neonatal Immunity and Infection Resistance Following Fetal Growth Restriction in Preterm Pigs |
Q37262438 | Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. |
Q38652231 | Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review |
Q35550564 | Infection-induced vulnerability of perinatal brain injury |
Q40997854 | Influence of a combination of probiotics on bacterial infections in very low birthweight newborns. |
Q34084719 | Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice |
Q28280887 | Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine |
Q37144519 | Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb |
Q38123550 | Lactoferrin and the newborn: current perspectives |
Q33383907 | Late-onset Enterobacter cloacae sepsis in very-low-birth-weight neonates: experience in a medical center |
Q38347714 | Late-onset sepsis in preterm infants: update on strategies for therapy and prevention |
Q42659574 | Leukocytosis in very low birth weight neonates: associated clinical factors and neonatal outcomes |
Q35913692 | Long persistence of methicillin-susceptible strains of Staphylococcus aureus causing sepsis in a neonatal intensive care unit |
Q80824122 | Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis |
Q43196465 | Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome |
Q39644662 | M-ficolin concentrations in cord blood are related to circulating phagocytes and to early-onset sepsis |
Q37340565 | Management of neonatal sepsis by Gram-negative pathogens |
Q84615774 | Maternal vaginal colonisation by Staphylococcus aureus and newborn acquisition at delivery |
Q35855746 | Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants |
Q34875837 | Mode of delivery and other risk factors for Escherichia coli infections in very low birth weight infants |
Q36089992 | Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy |
Q33499101 | Neonatal enteral feeding tubes as loci for colonisation by members of the Enterobacteriaceae |
Q34634864 | Neonatal gram negative and Candida sepsis survival and neurodevelopmental outcome at the corrected age of 24 months |
Q34758294 | Neonatal immune adaptation of the gut and its role during infections |
Q34939198 | Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodies |
Q34492674 | Neonatal innate immunity to infectious agents |
Q34315813 | Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network |
Q36438111 | New antibiotic dosing in infants |
Q24243750 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in premature infants |
Q24188043 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24235455 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24236014 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24235911 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q24241292 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q24243599 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q38586596 | Outbreaks of extended spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units: a systematic review. |
Q36941006 | Pathogenesis of cerebral white matter injury of prematurity |
Q33940492 | Pathophysiology and treatment of septic shock in neonates. |
Q24187349 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q24236202 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q24248766 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q50451118 | Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro. |
Q36095091 | Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks. |
Q50853469 | Phenotypic differences in leucocyte populations among healthy preterm and full-term newborns. |
Q37260284 | Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. |
Q37589515 | Prevention of early onset group B streptococcal disease: controversial issues |
Q29399413 | Prevention of neonatal group B streptococcus disease in the 21st century |
Q37641957 | Pro-inflammatory immune responses in leukocytes of premature infants exposed to maternal chorioamnionitis or funisitis |
Q92708819 | Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis |
Q35939866 | Prolonged antibiotic use induces intestinal injury in mice that is repaired after removing antibiotic pressure: implications for empiric antibiotic therapy |
Q34602603 | Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants |
Q54393200 | Prophylactic intratracheal polymyxin B/surfactant prevents bacterial growth in neonatal Escherichia coli pneumonia of rabbits. |
Q34120557 | Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. |
Q27026247 | Risk assessment in neonatal early onset sepsis |
Q33940417 | Role of innate host defenses in susceptibility to early-onset neonatal sepsis. |
Q34134241 | Role of polymorphic variants as genetic modulators of infection in neonatal sepsis |
Q34730325 | Selective exposure of the fetal lung and skin/amnion (but not gastro-intestinal tract) to LPS elicits acute systemic inflammation in fetal sheep |
Q41136126 | Sepsis as a risk factor for neonatal morbidity in extremely preterm infants. |
Q36443316 | Sepsis in young infants with congenital heart disease |
Q33674676 | Sepsis-Related Mortality of Very Low Birth Weight Brazilian Infants: The Role of Pseudomonas aeruginosa |
Q87417915 | Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis |
Q30832049 | Single-Molecule Sequencing (PacBio) of the Staphylococcus capitis NRCS-A Clone Reveals the Basis of Multidrug Resistance and Adaptation to the Neonatal Intensive Care Unit Environment |
Q46321666 | Subgaleal abscess and E. coli septicemia following scalp electrode in a preterm newborn: a case report |
Q37502638 | T-cell subpopulations αβ and γδ in cord blood of very preterm infants: the influence of intrauterine infection |
Q36905009 | Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18. |
Q40377045 | The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study |
Q35349957 | The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. |
Q45264818 | The changing characteristics of neonatal sepsis in the neonatal intensive care unit: a never-ending challenge |
Q34995998 | The developing oligodendrocyte: key cellular target in brain injury in the premature infant |
Q33950741 | The host response to sepsis and developmental impact |
Q43870067 | The impact of group B streptococcus prophylaxis on late-onset neonatal infections |
Q35819659 | The molecular characterisation of Escherichia coli K1 isolated from neonatal nasogastric feeding tubes |
Q35570164 | Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants |
Q37390368 | Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future |
Q35643346 | Very late onset infections in the neonatal intensive care unit |
Search more.